🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary aim this prospective, randomized, double-blind, placebo-control...
Status
Completed
Location
Erol Karaaslan
Start Date
2018-12-20
Trial ID
NCT03783312
Treatments Being Tested
This is a randomized, double-blind, double-dummy, multicenter, global Phase...
Status
Completed
Location
Trius investigator site 159
Start Date
2011-09-15
Trial ID
NCT01421511
This is a Phase 2/3, multicenter, randomized, double-blind, placebo-control...
Status
Terminated
Location
Yale University
Start Date
2019-09-04
Trial ID
NCT03907072
Treatments Being Tested
The purpose of the study is to evaluate post-op pain requirements in patien...
Status
Completed
Location
Kettering Medical Center
Start Date
2014-09
Trial ID
NCT02244619
Treatments Being Tested
Study Hypothesis: Preterm infants administered weekly Darbe during the neon...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-09-20
Trial ID
NCT03169881
Treatments Being Tested
The aim is to elucidate how NO works in conjunction with other neurotransmi...
Status
Completed
Location
Uppsala University
Start Date
2013-06
Trial ID
NCT02245165
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Completed
Location
Institut Bergonie
Start Date
2007-01-23
Trial ID
NCT00467142
Treatments Being Tested
The primary purpose of this study is to assess the efficacy of oral TBP-PI-...
Status
Completed
Location
Medical facility
Start Date
2023-12-21
Trial ID
NCT06059846
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
Arizona Oncology Associates, PC- HAL ( Site 8018)
Start Date
2017-06-09
Trial ID
NCT03142334
Treatments Being Tested
TQB2618 is a TIM-3 receptor monoclonal antibody that binds to the extracell...
Status
Unknown
Location
Cancer Hospital of The University of Chinese Academy of Sciences
Start Date
2020-12-01
Trial ID
NCT04623892
Treatments Being Tested